These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Help, hinder, hide and harm: what can we learn from the interactions between Limoli DH; Hoffman LR Thorax; 2019 Jul; 74(7):684-692. PubMed ID: 30777898 [TBL] [Abstract][Full Text] [Related]
5. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)]. Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048 [TBL] [Abstract][Full Text] [Related]
6. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)]. Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430 [TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa Increases the Sensitivity of Biofilm-Grown Staphylococcus aureus to Membrane-Targeting Antiseptics and Antibiotics. Orazi G; Ruoff KL; O'Toole GA mBio; 2019 Jul; 10(4):. PubMed ID: 31363032 [No Abstract] [Full Text] [Related]
8. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)]. Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305 [TBL] [Abstract][Full Text] [Related]
9. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)]. Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860 [TBL] [Abstract][Full Text] [Related]
10. [Susceptibility of bacteria isolated from the patients with lower respiratory tract infections to antibiotics (1985)]. Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Saito A; Shinohara M; Matsumiya H; Ueda K; Terai T Jpn J Antibiot; 1987 Sep; 40(9):1669-97. PubMed ID: 3121887 [TBL] [Abstract][Full Text] [Related]
14. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)]. Goto H; Takeda H; Kawai S; Watanabe S; Okazaki M; Shimada K; Nakano K; Yokouchi H; Mori T; Igari J; Oguri T; Yamamoto M; Kudo K; Kobayashi N; Tanaka T; Yoshimura K; Kawabata M; Nakamori Y; Sumitomo M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Aoki N; Honma Y; Suzuki Y; Karasawa Y; Oka M; Kobashi Y; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Oikawa S Jpn J Antibiot; 2008 Aug; 61(4):209-40. PubMed ID: 19024644 [TBL] [Abstract][Full Text] [Related]
15. [Susceptibility of bacteria isolated from lower respiratory tract infections to antibiotics (1983)]. Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Saito A; Shinohara M; Matsumiya H; Ueda K; Ida S Jpn J Antibiot; 1985 Nov; 38(11):3119-44. PubMed ID: 3937915 [TBL] [Abstract][Full Text] [Related]
16. Pharyngeal colonization and drug resistance profiles of Morraxella catarrrhalis, Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae among HIV infected children attending ART Clinic of Felegehiwot Referral Hospital, Ethiopia. Mulu W; Yizengaw E; Alemu M; Mekonnen D; Hailu D; Ketemaw K; Abera B; Kibret M PLoS One; 2018; 13(5):e0196722. PubMed ID: 29746496 [TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa PA14 Enhances the Efficacy of Norfloxacin against Staphylococcus aureus Newman Biofilms. Orazi G; Jean-Pierre F; O'Toole GA J Bacteriol; 2020 Aug; 202(18):. PubMed ID: 32661077 [TBL] [Abstract][Full Text] [Related]
18. Clinical resistance encountered in the respiratory surveillance program (RESP) study: a review of the implications for the treatment of community-acquired respiratory tract infections. Ehrhardt AF; Russo R Am J Med; 2001 Dec; 111 Suppl 9A():30S-35S discussion 36S-38S. PubMed ID: 11755441 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of bacterial resistance to antibiotics in infections of COPD patients. Kyd JM; McGrath J; Krishnamurthy A Curr Drug Targets; 2011 Apr; 12(4):521-30. PubMed ID: 21194403 [TBL] [Abstract][Full Text] [Related]